Validation of the Turkish Version of QUALEFFO-31

Bugra Ince

Status: Terminated

Conditions: Osteoporosis

Treatments: Other: Testing the Quality of Life Questionnaire of the European Foundation for Osteoporosis-31(QUALEFFO-31)

Study type: Observational

Funder types: Other

Identifiers

NCT04259099

54022451-050.05.04-01/16

Details and patient eligibility

About

The aim of this study is to investigate the adaptation and validity of the Quality of Life Questionnaire of the European Foundation for Osteoporosis-31 in patients with osteoporosis. Thus, to present a scale that will help us analyze the psychometric properties of patients with osteoporosis to the use of the Turkish people .

Full description

Osteoporosis has become an important public health problem due to low bone mass, decreased bone strength and increased risk of fractures. Today, the measurement of quality of life plays an important role in the approach to diseases. Quality of Life Questionnaire of the European Foundation for Osteoporosis-41 (QUALEFFO-41) has been used for many years as a well-established and fully self-administered questionnaire. In the following years, a shorter and more practical version was needed because the QUALEFFO-41 contains many questions and takes a long time. For this reason, the questionnaire was updated in 2006 and the version of QUALEFFO-31 was made and the validity of the current questionnaire was shown. The aim of this study is to conduct the reliability and validity study of Turkish version of QUALEFFO-31 and to evaluate the power of the questionnaire to distinguish patients with osteoporosis.

Enrollment: 111 patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• To have Dual-energy X-ray absorptiometry (DXA) results and thoracolumbar lateral spine X-Rays taken for any reason in the last 6 months.
• To have calcium, phosphorus, parathormone (PTH) and 25-hydroxyvitamin D level in the last 3 months.
• To be independently ambulatory.
• To have a cognitive capacity to understand and complete the questionnaires.

Exclusion criteria

• To have malignancy.
• To have inflammatory diseases.
• To have a metabolic bone disease other than osteoporosis.
• To have neuromuscular diseases.

Trial design

111 participants in 1 patient group

QUALITY OF LIFE QUESTIONNAIRES

Description:

The group is anticipated to consist of 150 female and male with osteoporosis, osteopenia or normal bone mineral density.

Treatment:

Other: Testing the Quality of Life Questionnaire of the European Foundation for Osteoporosis-31(QUALEFFO-31)